Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome

被引：28
作者：
Yin, Dongmei [1 ,2 ]
de Groot, Philip G. [2 ]
Ninivaggi, Marisa [2 ]
Devreese, Katrien M. J. [3 ,4 ]
de Laat, Bas [1 ,2 ]
机构：
[1] Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[2] Synapse Res Inst, Dept Funct Coagulat, Maastricht, Netherlands
[3] Ghent Univ Hosp, Dept Lab Med, Coagulat Lab, Ghent, Belgium
[4] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium
来源：
THROMBOSIS AND HAEMOSTASIS | 2021年 / 121卷 / 09期
关键词：
antiphospholipid antibodies; β 2 glycoprotein I; lupus anticoagulant; prothrombin; thrombosis;
D O I：
10.1055/a-1344-4271
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background Patients positive for all three types of antiphospholipid antibodies (aPLs; triple positivity) have been identified for having a high risk for thrombotic events. However, the clinical significance of isolated lupus anticoagulant (LAC) positivity is debated. Objectives To investigate the clinical relevance of isolated LAC. Methods A total of 456 patients were enrolled in this study; 66 antiphospholipid syndrome patients and 390 control patients. The control group consisted of autoimmune patients ( n =91), patients with thrombosis but without aPLs ( n =127), and normal controls ( n =172). LAC, anticardiolipin (anti-CL), and anti-beta 2 glycoprotein I (anti-beta 2GPI) immunoglobulin G (IgG) and immunoglobulin M (IgM) were determined according to the International Society on Thrombosis and Haemostasis (ISTH) guidelines. Anti-CL and anti-beta 2GPI were measured by four different solid-phase platforms to overcome variability between test systems. The noncriteria IgA anti-CL and anti-beta 2GPI, antidomain I of beta 2GPI IgG, and antiphosphatidylserine/prothrombin antibodies (anti-PS/PT) IgG and IgM were detected according to the ISTH guidelines for solid-phase assays. Results In total, 70 patients were positive for LAC, of which 44 were negative for both anti-beta 2GPI and anti-CL antibodies. We found that isolated LAC proved to be strongly associated with vascular thrombosis (odds ratio [OR]: 7.3; 95% confidence interval [CI]: 3.3-16.1), even better than triple-positive samples (OR: 4.3; 95% CI: 1.6-12.2). The titers of the anti-PS/PT IgG and IgM were significantly higher in triple-positivity samples compared with samples with isolated LAC positivity. The majority of single LAC positives were anti-PS/PT-negative. We observed that LAC positivity was weaker in isolated LAC-positive patients compared with LAC activity in triple-positive patients. Conclusion Isolated LAC was highly associated with thrombosis. The presence of anti-PS/PT antibodies could not explain LAC positivity in isolated LAC. Isolated LAC showed a weaker LAC activity compared with triple-positive patients.
引用
收藏
页码：1220 / 1227
页数：8
相关论文
共 35 条
[1]   14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends [J].
Bertolaccini, Maria Laura ;
Amengual, Olga ;
Andreoli, Laura ;
Atsumi, Tatsuya ;
Chighizola, Cecilia B. ;
Forastiero, Ricardo ;
De Groot, Philip ;
Lakos, Gabriella ;
Lambert, Marc ;
Meroni, Pierluigi ;
Ortel, Thomas L. ;
Petri, Michelle ;
Rahman, Anisur ;
Roubey, Robert ;
Sciascia, Savino ;
Snyder, Melissa ;
Tebo, Anne E. ;
Tincani, Angela ;
Willis, Rohan .
AUTOIMMUNITY REVIEWS, 2014, 13 (09) :917-930
[2]   Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays [J].
Chayoua, W. ;
Kelchtermans, H. ;
Moore, G. W. ;
Musial, J. ;
Wahl, D. ;
de Laat, B. ;
Devreese, K. M. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) :2016-2023
[3]   Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms [J].
Chayoua, Walid ;
Kelchtermans, Hilde ;
Moore, Gary W. ;
Gris, Jean-Christophe ;
Musial, Jacek ;
Wahl, Denis ;
Zuily, Stephane ;
Gianniello, Francesca ;
Fontana, Pierre ;
Remijn, Jasper ;
Urbanus, Rolf T. ;
de Laat, Bas ;
Devreese, Katrien M. J. .
THROMBOSIS AND HAEMOSTASIS, 2019, 119 (05) :797-806
[4]  
de Groot PG., 2017, ANTIPHOSPHOLIPID SYN, P15
[5]   Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5 [J].
de Laat, Bas ;
Wu, Xiao-Xuan ;
van Lummel, Menno ;
Derksen, Ronald H. W. M. ;
de Groot, Philip G. ;
Rand, Jacob H. .
BLOOD, 2007, 109 (04) :1490-1494
[6]   Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C [J].
de Laat, Bas ;
Eckmann, Carel M. ;
van Schagen, Marlies ;
Meijer, Alexander B. ;
Mertens, Koen ;
van Mourik, Jan A. .
BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (08) :757-764
[7]   Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania A Community-Based Case-Control Study [J].
de Mast, Quirijn ;
Molhoek, Jessica E. ;
van der Ven, Andre J. ;
Gray, William K. ;
de Groot, Philip G. ;
Jusabani, Ahmed ;
Mugusi, Ferdinand ;
Urbanus, Rolf T. ;
Walker, Richard W. .
STROKE, 2016, 47 (10) :2589-2595
[8]   Extended persistence of antiphospholipid antibodies beyond the 12-week time interval: Association with baseline antiphospholipid antibodies titres [J].
Devignes, Jean ;
Smail-Tabbone, Malika ;
Herve, Alex ;
Cagninacci, Geoffroy ;
Devignes, Marie-Dominique ;
Lecompte, Thomas ;
Zuily, Stephane ;
Wahl, Denis .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (06) :726-730
[9]   Laboratory criteria for antiphospholipid syndrome: reply [J].
Devreese, K. M. J. . ;
Ortel, T. L. ;
Pengo, V. ;
de Laat, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) :2117-2119
[10]   Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH [J].
Devreese, K. M. J. ;
Ortel, T. L. ;
Pengo, V. ;
de Laat, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (04) :809-813
1234